BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37276931)

  • 21. Drug Reaction with Eosinophilia and Systemic Symptoms: A Complex Interplay between Drug, T Cells, and Herpesviridae.
    Ganeshanandan L; Lucas M
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug Rash with Eosinophilia and Systemic Symptoms (DRESS Syndrome).
    Mendes MFL; Fernandes DS; Brandão I
    Acta Medica (Hradec Kralove); 2023; 66(1):28-31. PubMed ID: 37384807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to: Momen et al's "Discriminating minor and major forms of drug reaction with eosinophilia and systemic symptoms: Facial edema aligns to the severe phenotype".
    Cheng HM; Tey HL
    J Am Acad Dermatol; 2021 Nov; 85(5):e303-e304. PubMed ID: 34302901
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.
    Tashiro Y; Azukizawa H; Asada H; Niihara H; Morita E; Yamauchi T; Mizukawa Y; Kusakabe Y; Numazawa S; Izumi M; Sueki H; Watanabe H
    J Dermatol; 2019 Mar; 46(3):226-233. PubMed ID: 30663091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.
    Hama N; Abe R; Gibson A; Phillips EJ
    J Allergy Clin Immunol Pract; 2022 May; 10(5):1155-1167.e5. PubMed ID: 35176506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pustular-type drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to carbamazepine with systemic muscle involvement.
    Matsuda H; Saito K; Takayanagi Y; Okazaki T; Kashima K; Ishikawa K; Kai Y; Takeo N; Hatano Y; Okamoto O; Fujiwara S
    J Dermatol; 2013 Feb; 40(2):118-22. PubMed ID: 23216243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukemoid reaction in minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: A brief report.
    Shea M; Weese K; Dhossche J
    Pediatr Dermatol; 2024; 41(1):141-142. PubMed ID: 37496096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug Rash with Eosinophilia and Systemic Symptoms Syndrome Caused by Itraconazole in a 17-Year-Old Girl.
    Pires Pereira H; Coutinho IA; Carrapatoso I; Todo-Bom A
    Pediatr Allergy Immunol Pulmonol; 2023 Dec; 36(4):143-146. PubMed ID: 37729075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms following nivolumab and ipilimumab in a pediatric patient with melanoma.
    Aljundi N; Utz Petry S; Moossavi M; Daveluy S
    Pediatr Dermatol; 2022 May; 39(3):486-487. PubMed ID: 35797209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features of drug-induced hypersensitivity syndrome to BRAF inhibitors with and without previous immune checkpoint inhibition: a review.
    Maloney NJ; Rana J; Yang JJ; Zaba LC; Kwong BY
    Support Care Cancer; 2022 Mar; 30(3):2839-2851. PubMed ID: 34546454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patch testing in drug reaction with eosinophilia and systemic symptoms (DRESS): A literature review.
    de Groot AC
    Contact Dermatitis; 2022 Jun; 86(6):443-479. PubMed ID: 35233782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DRESS/DiHS syndrome induced by Propylthiouracil: a case report.
    Shen Q; Wang Q; Zang H; Yu L; Cong X; Chen X; Chen L
    BMC Endocr Disord; 2023 Jan; 23(1):22. PubMed ID: 36691013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome.
    Bohm KJ; Ciralsky JB; Harp JL; Bajaj S; Sippel KC
    Cornea; 2016 Jun; 35(6):888-91. PubMed ID: 27078005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alopecia universalis after drug reaction with eosinophilia and systemic symptoms (Dress).
    Hollingsworth P; Paci K; Evans M; Miedema J; Morrell DS
    Pediatr Dermatol; 2020 Sep; 37(5):947-949. PubMed ID: 32524672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe graft-versus-host disease-like enterocolitis accompanied with cytomegalovirus-reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    Takamiyagi S; Iriki H; Asahina Y; Furuichi Y; Funakoshi T; Ichikawa M; Mikami Y; Okita H; Sakiyama T; Inazumi T; Amagai M; Takahashi H
    J Dermatol; 2022 Aug; 49(8):796-799. PubMed ID: 35502510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe skin eruption with features of drug reaction with eosinophilia and systemic symptoms (DRESS) during vemurafenib treatment of melanoma.
    Kohlmann J; Reschke R; Mockenhaupt M; Ziemer M
    J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):e242-e244. PubMed ID: 34704628
    [No Abstract]   [Full Text] [Related]  

  • 37. First case of DRESS syndrome caused by hydroxychloroquine with a positive patch test.
    Castro Jiménez A; Navarrete Navarrete N; Gratacós Gómez AR; Florido López F; García Rodríguez R; Gómez Torrijos E
    Contact Dermatitis; 2021 Jan; 84(1):50-51. PubMed ID: 32654163
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug reaction with eosinophilia and systemic symptoms: An emergency medicine focused review.
    Gottlieb M; Figlewicz MR; Rabah W; Buddan D; Long B
    Am J Emerg Med; 2022 Jun; 56():1-6. PubMed ID: 35338896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vancomycin-induced drug rash with eosinophilia and systemic symptoms (DRESS).
    Yuan K; Awan KS; Long J
    BMJ Case Rep; 2020 Feb; 13(2):. PubMed ID: 32024716
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug reaction with eosinophilia and systemic symptoms: A single center descriptive observational study.
    Sandhu S; Neema S; Vashisht D; Venugopal R; Sengupta P; Radhakrishnan S
    Dermatol Ther; 2021 Jan; 34(1):e14670. PubMed ID: 33314590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.